Danazol treatment and platelet function

Other OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

Danazol treatment for endometriosis significantly increased platelet count in women, with minor release defects appearing in some but likely only clinically relevant in those with pre-existing platelet issues.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Platelet count and platelet function have been studied in detail in 14 women before and during treatment with danazol for endometriosis. A progressive and highly significant increase in platelet count was recorded from the pretreatment value (311 x 10(9)/L) to the value after six months of treatment (366 x 10(9)/L; P less than 0.001). Five patients developed minor platelet release defects, which may have been caused by the drug. However, the abnormalities shown are only likely to be of clinical importance in patients with preexisting platelet abnormalities.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Blood Platelets Danazol Pregnadienes Bleeding Time Bleeding Time Blood Platelets Blood Platelets Danazol Danazol Danazol Endometriosis Endometriosis Endometriosis Female Female Humans Humans Platelet Adhesiveness Platelet Adhesiveness Platelet Adhesiveness

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (4)

References (7)

Cited by (4)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:58:42.677500+00:00
License: CC0 · commercial use OK